CONMED Corporation  

(Public, NASDAQ:CNMD)   Watch this stock  
Find more results for CNMD
42.87
+0.04 (0.09%)
After Hours: 42.87 0.00 (0.00%)
Mar 28, 4:38PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 42.19 - 42.90
52 week 37.60 - 50.16
Open 42.69
Vol / Avg. 108,315.00/171,000.00
Mkt cap 1.19B
P/E 81.90
Div/yield 0.20/1.87
EPS 0.52
Shares 27.84M
Beta 0.73
Inst. own 101%
Jan 25, 2017
Q4 2016 Conmed Corp Earnings Release (Estimated)
Jan 11, 2017
Conmed Corp at JPMorgan Healthcare Conference - Q&A session
Jan 11, 2017
Conmed Corp at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 3.29% 1.92%
Operating margin 6.18% 4.93%
EBITD margin - 16.53%
Return on average assets 2.02% 1.21%
Return on average equity 4.62% 2.52%
Employees 3,300 -
CDP Score - -

Address

525 French Rd
UTICA, NY 13502-5945
United States - Map
+1-315-6243215 (Phone)
+1-315-7970321 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

CONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. The Company provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. The Company's product lines consist of orthopedic surgery, general surgery and surgical visualization. As of December 31, 2016, the Company's products are distributed domestically directly to over 6,000 hospitals, surgery centers and other healthcare institutions, as well as through medical specialty distributors. The Company's orthopedic surgery product lines include sports medicine, powered surgical instruments, and sports biologics and tissue. These products are marketed under a range of brands, including Hall, CONMED Linvatec, Concept and Shutt.

Officers and directors

Mark E. Tryniski Independent Chairman of the Board
Age: 55
Bio & Compensation  - Reuters
Curt R. Hartman President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Luke A. Pomilio Chief Financial Officer, Executive Vice President - Finance
Age: 51
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Patrick J. Beyer President - CONMED International
Age: 50
Bio & Compensation  - Reuters
Daniel S. Jonas Executive Vice President - Legal Affairs, General Counsel
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Heather L. Cohen Executive Vice President of Human Resources, Secretary
Age: 43
Bio & Compensation  - Reuters
Wilfredo Ruiz-Caban Executive Vice President - Quality Assurance, Regulatory Affairs and Operations
Age: 51
Bio & Compensation  - Reuters
Peter K. Shagory Executive Vice President - Strategy and Corporate Development
Age: 47
Bio & Compensation  - Reuters
Nathan Folkert Vice President, General Manager - U.S. Orthopedics Business
Age: 41
Bio & Compensation  - Reuters
John E. Kennedy Vice President and General Manager - CET
Age: 58
Bio & Compensation  - Reuters